EMA рекомендує оновити склад вакцин проти COVID-19 для сезону 2026–2027

A constructive meeting between Biopharma and Site Head Stada Inna Udovenko took place on July 20, 2023. The goal was to discuss cooperation on testing Stada products, which will improve…

Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…